Hims & Hers Health (HIMS) Non-Current Deferred Tax Liability (2025 - 2026)

Hims & Hers Health's (HIMS) quarterly Non-Current Deferred Tax Liability came in at $23.5 million in Q1 2026, down 18.52% quarter-over-quarter from $28.9 million in Q4 2025.

Hims & Hers Health (HIMS) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

Hims & Hers Health has disclosed Non-Current Deferred Tax Liability across 2 years of filings, most recently posting $23.5 million for Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $23.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $23.5 million (changed N/A YoY), and the FY2025 annual result was $28.9 million, changed N/A from the prior year.
  • Non-Current Deferred Tax Liability came in at $23.5 million for Q1 2026 at Hims & Hers Health, down from $28.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $31.2 million in Q3 2025 to a low of $23.5 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.51 Mn
Mar 31, 2026 23.51 Mn
Dec 31, 2025 28.86 Mn
Dec 31, 2025 28.86 Mn
Sep 30, 2025 31.21 Mn
Sep 30, 2025 31.21 Mn